FMP
LakeShore Biopharma Co., Ltd.
LSBPW
NASDAQ
LakeShore Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.
0.0546 USD
0.0186 (34.07%)
Free Cash Flow
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Revenue
160.25M
151.47M
142.5M
136.53M
158.63M
158.87M
159.11M
159.34M
159.58M
159.82M
Revenue %
-
-5.48
-5.92
-4.19
16.19
0.15
0.15
0.15
0.15
Operating Cash Flow
78.67M
45.04M
40.77M
36.04M
57.35M
54.01M
54.09M
54.17M
54.25M
54.33M
Operating Cash Flow %
49.09
29.73
28.61
26.4
36.15
34
34
34
34
Cap Ex
-34.75M
-34.23M
-44.16M
-36.73M
-33.59M
-39.19M
-39.25M
-39.31M
-39.37M
-39.43M
Cap Ex %
-21.69
-22.6
-30.99
-26.9
-21.17
-24.67
-24.67
-24.67
-24.67
Free Cash Flow
43.91M
10.81M
-3.4M
-687k
23.76M
14.82M
14.84M
14.86M
14.88M
14.9M
